Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 1
2004 1
2006 1
2007 5
2008 4
2009 3
2010 5
2011 3
2012 1
2013 3
2014 4
2015 3
2016 4
2017 4
2020 2
2021 3
2023 4
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL.
Mazzara S, Travaini L, Botta F, Granata C, Motta G, Melle F, Fiori S, Tabanelli V, Vanazzi A, Ramadan S, Radice T, Raimondi S, Lo Presti G, Ferrari ME, Jereczek-Fossa BA, Tarella C, Ceci F, Pileri S, Derenzini E. Mazzara S, et al. Among authors: travaini l. Blood Adv. 2023 Feb 28;7(4):630-643. doi: 10.1182/bloodadvances.2022007825. Blood Adv. 2023. PMID: 36806558 Free PMC article.
Interim 18FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic review.
Ferrari M, Travaini LL, Ciardo D, Garibaldi C, Gilardi L, Glynne-Jones R, Grana CM, Jereczek-Fossa BA, Marvaso G, Ronchi S, Leonardi MC, Orecchia R, Cremonesi M. Ferrari M, et al. Among authors: travaini ll. Crit Rev Oncol Hematol. 2017 May;113:28-42. doi: 10.1016/j.critrevonc.2017.02.019. Epub 2017 Feb 20. Crit Rev Oncol Hematol. 2017. PMID: 28427517
(18)F-fluorodeoxyglucose PET/CT ((18)F-FDG-PET/CT) is widely applied in oncology for disease staging, assessment of therapy response, relapse diagnosis, follow-up and target volume delineation. ...
(18)F-fluorodeoxyglucose PET/CT ((18)F-FDG-PET/CT) is widely applied in oncology for disease staging, assessment of therapy response, …
[18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma.
Airò Farulla LS, Travaini LL, Cuomo M, Galetta D, Mattana F, Frassoni S, Buonsanti G, Muraglia L, Zuccotti GA, Bagnardi V, Spaggiari L, Ceci F. Airò Farulla LS, et al. Among authors: travaini ll. Tomography. 2023 Feb 10;9(1):387-397. doi: 10.3390/tomography9010031. Tomography. 2023. PMID: 36828383 Free PMC article.
Imaging as a surveillance tool in rectal cancer.
Bellomi M, Travaini LL. Bellomi M, et al. Among authors: travaini ll. Expert Rev Med Devices. 2010 Jan;7(1):99-112. doi: 10.1586/erd.09.63. Expert Rev Med Devices. 2010. PMID: 20021242 Review.
Interim 18F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review.
Garibaldi C, Ronchi S, Cremonesi M, Gilardi L, Travaini L, Ferrari M, Alterio D, Kaanders JHAM, Ciardo D, Orecchia R, Jereczek-Fossa BA, Grana CM. Garibaldi C, et al. Among authors: travaini l. Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):555-573. doi: 10.1016/j.ijrobp.2017.02.217. Epub 2017 Mar 4. Int J Radiat Oncol Biol Phys. 2017. PMID: 28581396
Positron emission tomography (PET) is an imaging modality widely applied in oncology for tumor staging, volume delineation in radiation therapy planning, and therapy response assessment. ...
Positron emission tomography (PET) is an imaging modality widely applied in oncology for tumor staging, volume delineation in radiati …
50 results